Treatment of Non-small Cell Lung Cancer Stage I and Stage II

2007/09/01 by Walter J. Scott, John Howington, John A. Howington +5 · 26 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Lung Cancer Diagnosis and Treatment #Radiomics and Machine Learning in Medical Imaging #Breast Cancer Treatment Studies

paper · doi:10.1378/chest.07-1378

Citations

• Stereotactic hypofractionated high‐dose irradiation for stage I nonsmall cell lung carcinoma

Cited by

• Artificial intelligence in lung cancer diagnosis and prognosis: Current application and future perspective
• Surgery for early stage non-small cell lung cancer. [europepmc]
• Results from the national sepsis practice survey: predictions about mortality and morbidity and recommendations for limitation of care orders. [europepmc]
• miRNAs in lung cancer - studying complex fingerprints in patient's blood cells by microarray experiments. [europepmc]
• Identification of lung cancer with high sensitivity and specificity by blood testing. [europepmc]
• Using claims-based measures to predict performance status score in patients with lung cancer. [europepmc]
• Palliative care in lung cancer. [europepmc]
• Factors associated with adherence to chemotherapy guidelines in patients with non-small cell lung cancer. [europepmc]
• A decade of advances in treatment of early-stage lung cancer. [europepmc]
• Overexpression of T-LAK cell-originated protein kinase predicts poor prognosis in patients with stage I lung adenocarcinoma. [europepmc]
• Atrial fibrillation after pulmonary lobectomy for lung cancer affects long-term survival in a prospective single-center study. [europepmc]
• Array-comparative genomic hybridization reveals loss of SOCS6 is associated with poor prognosis in primary lung squamous cell carcinoma. [europepmc]
• Molecular imaging for cancer diagnosis and surgery. [europepmc]
• The blood-borne miRNA signature of lung cancer patients is independent of histology but influenced by metastases. [europepmc]
• Non-grasping en bloc mediastinal lymph node dissection for video-assisted thoracoscopic lung cancer surgery. [europepmc]
• Layered superhydrophobic meshes for controlled drug release. [europepmc]
• Sublobar resection versus lobectomy in Surgical Treatment of Elderly Patients with early-stage non-small cell lung cancer (STEPS): study protocol for a randomized controlled trial. [europepmc]
• Comparison of the Effectiveness of Radiofrequency Ablation With Stereotactic Body Radiation Therapy in Inoperable Stage I Non-Small Cell Lung Cancer: A Systemic Review and Pooled Analysis. [europepmc]
• The Impact of Preexisting Mental Health Disorders on the Diagnosis, Treatment, and Survival among Lung Cancer Patients in the U.S. Military Health System. [europepmc]
• Predicting microRNA-disease associations using bipartite local models and hubness-aware regression. [europepmc]
• Isoliquiritigenin inhibits cell proliferation and migration through the PI3K/AKT signaling pathway in A549 lung cancer cells. [europepmc]
• CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in Stage I, II resectable Non-Small Cell Lung Cancer: a retrospective multi-cohort study for outcome prediction. [europepmc]
• EFHD2 contributes to non-small cell lung cancer cisplatin resistance by the activation of NOX4-ROS-ABCC1 axis. [europepmc]
• Nanomedicine in Non-Small Cell Lung Cancer: From Conventional Treatments to Immunotherapy. [europepmc]
• Neoadjuvant immunotherapy for non-small cell lung cancer: State of the art. [europepmc]
• Comparison Between Wedge Resection and Lobectomy/Segmentectomy for Early-Stage Non-small Cell Lung Cancer: A Bayesian Meta-analysis and Systematic Review. [europepmc]